Is Emergent BioSolutions Inc. overvalued?

Emergent BioSolutions Inc. (EBS) looks undervalued — trading about 242% below its fair value.

Undervalued

Price

$6.86

Fair value

$23.47

Current P/E

6.9

Normal P/E

23.5

Market cap

$354.0M

Dividend yield

0.0%

Return on equity

-35.9%

Sector

Healthcare

Fair value compares EBS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks